These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 2439401)
1. Long-term follow-up of patients who underwent yttrium-90 pituitary implantation for treatment of proliferative diabetic retinopathy. Sharp PS; Fallon TJ; Brazier OJ; Sandler L; Joplin GF; Kohner EM Diabetologia; 1987 Apr; 30(4):199-207. PubMed ID: 2439401 [TBL] [Abstract][Full Text] [Related]
2. Three-year safety and visual acuity results of epimacular 90 strontium/90 yttrium brachytherapy with bevacizumab for the treatment of subfoveal choroidal neovascularization secondary to age-related macular degeneration. Avila MP; Farah ME; Santos A; Carla L; Fuji G; Rossi J; Nau J Retina; 2012 Jan; 32(1):10-8. PubMed ID: 21817963 [TBL] [Abstract][Full Text] [Related]
3. Photocoagulation in diabetic retinopathy. A multicentre study in Sweden. Stenkula S Acta Ophthalmol Suppl; 1984; 162():1-100. PubMed ID: 6324526 [TBL] [Abstract][Full Text] [Related]
4. Computer analysis of ocular results following selective blockade of growth-hormone in diabetic retinopathy. A collaborative study. Schaub C; Boujard O; Brouard N; Drouin P; Le Devehat C; Lemoine A; Mejean L; Mounier F; Regnault F; Saudax A Metab Ophthalmol; 1984-1985; 8(1):35-42. PubMed ID: 6394947 [TBL] [Abstract][Full Text] [Related]
5. [Trial treatment of diabetic retinopathy by inhibition of pituitary somatotropin secretion with MAP]. Bruni B; Bruni-Bocher K; Della Valle A; Gamba S Minerva Med; 1975 Mar; 66(21):1001-23. PubMed ID: 1124148 [TBL] [Abstract][Full Text] [Related]
6. [Stereotaxic pituitary implantation of radio-gold in the treatment of severe diabetic retinopathy. Long term results (author's transl)]. Mirouze J; Schmouker Y; Cartry E Nouv Presse Med; 1980 Mar; 9(10):687-91. PubMed ID: 6990381 [TBL] [Abstract][Full Text] [Related]
7. Diabetic retinopathy. Screening and prevention of blindness. A doctoral thesis. Kristinsson JK Acta Ophthalmol Scand Suppl; 1997; (223):1-76. PubMed ID: 9559048 [TBL] [Abstract][Full Text] [Related]
8. [Results of laser photocoagulation in patients with diabetic retinopathy developed as a complication of diabetes type 2]. Wilczyński M; Dzivgielewski K Klin Oczna; 2006; 108(1-3):66-9. PubMed ID: 16883944 [TBL] [Abstract][Full Text] [Related]
9. Octreotide reduces vitreous hemorrhage and loss of visual acuity risk in patients with high-risk proliferative diabetic retinopathy. Boehm BO; Lang GK; Jehle PM; Feldman B; Lang GE Horm Metab Res; 2001 May; 33(5):300-6. PubMed ID: 11440277 [TBL] [Abstract][Full Text] [Related]
10. Progression of nonproliferative diabetic retinopathy and visual outcome after extracapsular cataract extraction and intraocular lens implantation. Jaffe GJ; Burton TC; Kuhn E; Prescott A; Hartz A Am J Ophthalmol; 1992 Oct; 114(4):448-56. PubMed ID: 1415456 [TBL] [Abstract][Full Text] [Related]
11. Interstitial pituitary irradiation with 90Y for the treatment of acromegaly. A reappraisal. Cassar J; Doyle FH; Banks LM; Jadresic A; Mashiter K; Joplin GF Acta Endocrinol (Copenh); 1981 Mar; 96(3):295-300. PubMed ID: 7211092 [TBL] [Abstract][Full Text] [Related]